Ocugen, Inc. Insider Trading for December 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocugen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocugen, Inc. for December 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19 2016 | HSGX | HISTOGENICS CORP | Gridley Adam | See Remarks | Option Exercise | A | 1.58 | 175,000 | 276,500 | 175,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | Baltzell Joshua J | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | JOHNSON JOHN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | Kong Garheng | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 19 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 1.58 | 10,000 | 15,800 | 10,000 | |
| Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.65 | 3,000 | 4,950 | 8,000 | 5 K to 8 K (+60.00 %) |
| Dec 15 2016 | HSGX | HISTOGENICS CORP | GILL DAVID N | Director | Buy | P | 1.92 | 5,000 | 9,600 | 5,000 | 0 to 5 K |
| Dec 06 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | C | 0.00 | 2,243 | 0 | 0 | |
| Dec 06 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Buy | C | 0.00 | 996,779 | 0 | 3,072,110 | 2.1 M to 3.1 M (+48.03 %) |
| Dec 05 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | C | 0.00 | 2,243 | 0 | 0 | |
| Dec 05 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Buy | C | 0.00 | 996,779 | 0 | 3,072,110 | 2.1 M to 3.1 M (+48.03 %) |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 200 | 0 | 0 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 60 | 0 | 0 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | C | 0.00 | 60 | 0 | 0 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 88,998 | 0 | 228,196 | 139.2 K to 228.2 K (+63.94 %) |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 26,699 | 0 | 139,198 | 112.5 K to 139.2 K (+23.73 %) |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Buy | C | 0.00 | 26,699 | 0 | 112,499 | 85.8 K to 112.5 K (+31.12 %) |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Buy | P | 1.95 | 5,000 | 9,731 | 5,000 | 0 to 5 K |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | Gridley Adam | President and CEO | Buy | P | 2.01 | 5,000 | 10,040 | 5,000 | 0 to 5 K |